Related Experiment Video
Updated: Oct 3, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Safety of a new conjugate meningococcal C vaccine in infants
R Lakshman1, I Jones, D Walker
1Sheffield Institute for Vaccine Studies, Sheffield Children's Hospital, Sheffield S10 2TH, UK. R.Lakshman@sheffield.ac.uk
Insights
The Chiron Group C meningococcal conjugate vaccine (Men C) showed a low incidence of adverse events in infants. Most adverse events were mild and not vaccine-related, with no serious events definitively linked to the vaccine.
Area of Science:
- Pediatric immunology
- Vaccine safety research
- Public health
Background:
- Group C meningococcal conjugate vaccines (Men C) were integrated into the UK's routine infant immunization schedule in November 1999.
- Significant professional and public attention has focused on the efficacy and safety profiles of Men C vaccines.
Purpose of the Study:
- To assess the incidence of uncommon adverse events in infants following administration of the Chiron Men C vaccine.
- To evaluate the safety of the Chiron Men C vaccine in a large infant cohort.
Main Methods:
- A prospective study involving 2796 infants aged approximately 2 months, vaccinated at 2, 3, and 4 months with the Chiron Men C vaccine alongside routine immunizations.
- Active and prospective data collection on adverse events for one month post-vaccination, with thorough review for potential vaccine association.
- Study conducted in Sheffield and Scotland.
Main Results:
- No deaths were reported. No serious adverse events were definitively or probably linked to the vaccine.
- Four infants experienced serious adverse events (hypotonia, screaming syndrome, maculopapular rash, agitation) possibly related to the vaccine; all recovered fully.
- Of 1804 reported adverse events, only 49 (1.8%) were considered possibly vaccine-related. No recurrences of possibly related adverse events were observed upon subsequent immunizations.
Conclusions:
- The Chiron Men C vaccine demonstrated a favorable safety profile in infants.
- The incidence of serious adverse events possibly related to the vaccine was low, with complete recovery observed.
- The study supports the safety of Men C vaccination in infants as part of routine immunization schedules.
Background:
Group C conjugate meningococcal vaccines (Men C) were introduced into the UK primary immunisation schedule in November 1999. There has been extensive professional and public interest in their efficacy and safety.
Aim:
To determine the occurrence of at least one uncommon adverse event in infants related to the administration of the Chiron Men C vaccine.
Methods:
A total of 2796 infants aged approximately 2 months were recruited into the study from areas in and around Sheffield and from Scotland. They were vaccinated with the Chiron Men C vaccine at 2, 3, and 4 months along with routine immunisations. Data on adverse events occurring one month after each dose were collected actively and prospectively and reviewed for possible relation to the vaccine.
Results:
There were no deaths. There were no serious adverse events considered definitely or probably caused by the vaccine. Four infants developed serious adverse events (hypotonia, screaming syndrome, maculopapular rash, and agitation, respectively) that were considered possibly related to the vaccine. All recovered completely. Adverse events were seen in 1804 children but were considered possibly related to the vaccine in only 49 (1.8%). On subsequent immunisation there were no recurrences of adverse events considered to be possibly related to the vaccine.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Related Concept Videos
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Respiratory Syncytial Virus Disease
Cytomegalovirus Disease
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Viral Meningitis